Stay updated on Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial
Sign up to get notified when there's something new on the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page.

Latest updates to the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedUpdate includes operating-status notice and a resource removal, plus a version bump to v3.2.0; core content and a specific topic (Gastrointestinal stromal tumor) were affected.SummaryDifference6%

- Check23 days agoChange DetectedUpgrade to v3.1.0 (from v3.0.2); a new revision tag is added and an identifier (008613601310849) is introduced, indicating a new release without altering core content or critical data.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated to v3.0.2 from v3.0.1; the 'Back to Top' link was removed. No substantive core content changes were observed.SummaryDifference0.3%

- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.3%

- Check51 days agoChange DetectedThe web page has updated its facility name and location details, specifically clarifying the geographical context by including 'Beijing Municipality' and the drug 'anlotinib' related to gastrointestinal stromal tumors.SummaryDifference2%

- Check66 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page.